Divalproex Sodium Versus Valproic Acid in Hospital Treatment of Psychotic Disorders
AUTOR(ES)
Schwartz, Thomas L.
FONTE
Physicians Postgraduate Press
RESUMO
Background: Approximately 50% of pharmacy prescriptions in the United States are filled with generic drugs, which have improved substantially in quality owing to increased governmental regulations. The remaining medicoeconomic question regards whether or not brand-name medications are worth the price. This study evaluates these questions for the brand-name mood stabilizer divalproex sodium and its generic counterpart, valproic acid.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181204Documentos Relacionados
- Rethinking the Treatment of Psychotic Disorders
- The cost of treatment of dermatological disorders in hospital versus health centre.
- Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
- Actual bioavailability of divalproex sodium extended-release tablets and its clinical implications
- Valproic acid-associated encephalopathy.
